scispace - formally typeset
P

Pär Gerwins

Researcher at Uppsala University

Publications -  31
Citations -  1731

Pär Gerwins is an academic researcher from Uppsala University. The author has contributed to research in topics: Angiogenesis & Vascular endothelial growth factor A. The author has an hindex of 18, co-authored 31 publications receiving 1537 citations. Previous affiliations of Pär Gerwins include Uppsala University Hospital.

Papers
More filters
Journal ArticleDOI

Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis

TL;DR: This review will focus on two important types of angiogenic growth factors, vascular endothelial growth factor (VEGF) and fibroblast growth factors (FGF), which bind to cell surface expressed receptors, which are ligand-stimulatable tyrosine kinases.
Journal ArticleDOI

Biomechanical regulation of blood vessel growth during tissue vascularization.

TL;DR: It is shown here that neovascularization can be accomplished by nonangiogenic expansion of preexisting vessels by exploiting tissue tension generated by activated fibroblasts or myofibroblast during wound contraction mediated and directed translocation of the vasculature.
Journal ArticleDOI

p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis.

TL;DR: Results implicate p38 in organization of new vessels and suggest that p38 is an essential regulator of FGF-2–driven angiogenesis, which is suggested to be an essential regulation of growth factor–dependent cellular functions.
Journal ArticleDOI

Identification and characterization of VEGF-A–responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans

TL;DR: In this paper, the authors investigated the mechanisms underlying neutrophil recruitment to VEGF-A as well as the characteristics of these neutrophils, and found that parallel activation of VEGFR1 and VEGFC2 was required for VEGf-A-induced recruitment of circulating neutrophILS to tissue.
Journal ArticleDOI

Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer.

TL;DR: It is shown that, among angiogenic growth factors, VEGF-A is a specific inducer of endocan transcription which is translated into increased protein levels in VEGf-A treated endothelial cells.